Stockhub

Basilea Pharmaceutica AG: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

17 August 2022

  • curprev 06:0906:09, 17 August 2022 >Paris 1,174 bytes +1,174 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Basilea Pharmaceutica AG, a commercial stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. It offers Cresemba, an intravenous and oral azole antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union, as well as in Phase III clinical trials for invasive f..."
Retrieved from "https://stockhub.co/research/Basilea_Pharmaceutica_AG"